Clinical trial

The Role of Aldosterone in Circulatory Disorders Within Type 2 Diabetes

NCT03017703

Study summary

ClinicalTrials.gov

The Role of Aldosterone in Circulatory Disorders Within Type 2 Diabetes

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Eplerenone Normalized identity: eplerenone View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-12-01

PhaseNA

Conditions

Endothelial Dysfunctionunresolved

Insulin Resistanceunresolved

Interventions

EplerenoneDRUG · verified · RxNorm: eplerenone

Sponsors & collaborators

University of Southern Denmarklead sponsor

Mapped research locations

OdenseDenmark1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03017703 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.